Interpace Biosciences IDXG Stock
Interpace Biosciences Price Chart
Interpace Biosciences IDXG Financial and Trading Overview
| Interpace Biosciences stock price | 1.5 USD |
| Previous Close | 1.52 USD |
| Open | 1.45 USD |
| Bid | 1.41 USD x 10000 |
| Ask | 1.43 USD x 10000 |
| Day's Range | 1.43 - 1.45 USD |
| 52 Week Range | 0.77 - 2.4 USD |
| Volume | 1.1K USD |
| Avg. Volume | 5.41K USD |
| Market Cap | 39.61M USD |
| Beta (5Y Monthly) | 0.606 |
| PE Ratio (TTM) | 1.4895833 |
| EPS (TTM) | 0.9 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IDXG Valuation Measures
| Enterprise Value | 37.9M USD |
| Trailing P/E | 1.4895833 |
| Forward P/E | -9.533333 |
| PEG Ratio (5 yr expected) | 0.36 |
| Price/Sales (ttm) | 1.0959576 |
| Price/Book (mrq) | 1.70441 |
| Enterprise Value/Revenue | 1.049 |
| Enterprise Value/EBITDA | 8.152 |
Trading Information
Interpace Biosciences Stock Price History
| Beta (5Y Monthly) | 0.606 |
| 52-Week Change | 68.23% |
| S&P500 52-Week Change | 18.35% |
| 52 Week High | 2.4 USD |
| 52 Week Low | 0.77 USD |
| 50-Day Moving Average | 1.59 USD |
| 200-Day Moving Average | 1.6 USD |
IDXG Share Statistics
| Avg. Volume (3 month) | 5.41K USD |
| Avg. Daily Volume (10-Days) | 12.42K USD |
| Shares Outstanding | 27.7M |
| Float | 1.8M |
| Short Ratio | 0.19 |
| % Held by Insiders | 91.18% |
| % Held by Institutions | 0% |
| Shares Short | 47.36K |
| Short % of Float | 1.17% |
| Short % of Shares Outstanding | 1.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 67.63% |
| Operating Margin (ttm) | 3.51% |
| Gross Margin | 63.74% |
| EBITDA Margin | 12.86% |
Management Effectiveness
| Return on Assets (ttm) | 11.13% |
| Return on Equity (ttm) | 225.68% |
Income Statement
| Revenue (ttm) | 36.14M USD |
| Revenue Per Share (ttm) | 2.47 USD |
| Quarterly Revenue Growth (yoy) | -1.099% |
| Gross Profit (ttm) | 23.04M USD |
| EBITDA | 4.65M USD |
| Net Income Avi to Common (ttm) | 24.86M USD |
| Diluted EPS (ttm) | 0.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.69M USD |
| Total Cash Per Share (mrq) | 0.1 USD |
| Total Debt (mrq) | 974K USD |
| Total Debt/Equity (mrq) | 4.19 USD |
| Current Ratio (mrq) | 2.215 |
| Book Value Per Share (mrq) | 0.839 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.46M USD |
| Levered Free Cash Flow (ttm) | 3.42M USD |
Profile of Interpace Biosciences
| Country | United States |
| State | NJ |
| City | Parsippany |
| Address | Waterview Plaza |
| ZIP | 07054 |
| Phone | 855 776 6419 |
| Website | https://www.interpace.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 102 |
Interpace Biosciences, Inc. provides molecular diagnostic tests and pathology services for evaluating cancer risk in the United States. It offers ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. The company also provides ThyraMIR v2, which assesses thyroid nodules for malignancy risk using a proprietary microRNA gene expression classifier. It primarily serves physicians, cancer centers, clinics, laboratories, pathology groups, and hospitals. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
Q&A For Interpace Biosciences Stock
What is a current IDXG stock price?
Interpace Biosciences IDXG stock price today per share is 1.5 USD.
How to purchase Interpace Biosciences stock?
You can buy IDXG shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Interpace Biosciences?
The stock symbol or ticker of Interpace Biosciences is IDXG.
Which industry does the Interpace Biosciences company belong to?
The Interpace Biosciences industry is Diagnostics & Research.
How many shares does Interpace Biosciences have in circulation?
The max supply of Interpace Biosciences shares is 27.7M.
What is Interpace Biosciences Price to Earnings Ratio (PE Ratio)?
Interpace Biosciences PE Ratio is 1.66666670 now.
What was Interpace Biosciences earnings per share over the trailing 12 months (TTM)?
Interpace Biosciences EPS is 0.9 USD over the trailing 12 months.
Which sector does the Interpace Biosciences company belong to?
The Interpace Biosciences sector is Healthcare.
Interpace Biosciences IDXG included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Capital Market Composite
RCMP
US
|
143.17 USD — |
-1.1
|
— — | 142.97 USD — | 144.46 USD — | — - | — — |
|
US Tech Industrial
INDS
US
|
12859.95 USD — |
-0.48
|
— — | 12822.72 USD — | 12921.45 USD — | — - | — — |
- {{ link.label }} {{link}}
